全球因 COVID-19 导致的药品短缺：对患者护理的影响和缓解策略。
Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
机构信息
Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
出版信息
Res Social Adm Pharm. 2021 Jan;17(1):1946-1949. doi: 10.1016/j.sapharm.2020.05.017. Epub 2020 May 19.
Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.
2019 年冠状病毒病（COVID-19）源自中国武汉，目前正在全球爆发。世界卫生组织（WHO）已宣布 COVID-19 为全球大流行。COVID-19 可能导致从自限性发热、喉咙痛和咳嗽到更严重的症状，这些症状可能导致急性呼吸窘迫综合征。由于封锁和需求增加，药物短缺可能成为一个日益严重的全球问题。本文旨在探讨由于这种大流行导致的药物短缺对患者结局的潜在影响，以及药剂师和药房政策制定者在缓解这一新兴问题方面的作用。
Zotero 插件